Top 10 Companies in the Global Methyl Boronic Acid Market (2026): Market Leaders Powering Innovation

MARKET INSIGHTS

Global Methyl Boronic Acid market size was valued at USD 21.3 million in 2025 and is projected to grow from USD 22.8 million in 2026 to USD 39.5 million by 2034, exhibiting a CAGR of 7.1% during the forecast period.

Methyl Boronic Acid (CH3B(OH)2) is an organoboron compound widely used as a key reagent in organic synthesis, particularly in Suzuki‑Miyaura cross‑coupling reactions. These reactions are fundamental for creating carbon‑carbon bonds in pharmaceutical intermediates, agrochemicals, and advanced materials. The compound’s unique properties make it indispensable in the synthesis of complex molecular structures for various industries.

Pharmaceutical applications dominate market demand, with the compound playing a critical role in developing active pharmaceutical ingredients (APIs) for oncology and neurological treatments. Recent expansions by major chemical manufacturers like TCI Chemicals and Abblis Chemicals have increased production capacities to meet growing demand. The market also benefits from increasing R&D investments in green chemistry methods to improve production efficiency and reduce environmental impact.

Global Methyl Boronic Acid Market – View in Detailed Research Report

🔟 1. TCI (Tokyo Chemical Industry Co., Ltd.)

Headquarters: Tokyo, Japan
Key Offering: High‑purity Methyl Boronic Acid for pharmaceutical and research use

TCI’s in‑house synthesis and rigorous quality control make it the most trusted source for reagent‑grade boronic acids. The company’s investment in advanced purification technologies keeps batch consistency above 99.9% purity, satisfying the strictest ICH guidelines required by global pharma clients.

Sustainability & Growth Initiatives

• Implementation of closed‑loop water recycling in the synthesis plant to reduce water consumption by 25%
• Partnership with universities to develop bio‑based boron precursors, cutting fossil‑fuel inputs
• Expansion of production capacity by 30% to support rising demand for oncology APIs

---

9️⃣ 2. Combi‑Blocks

Headquarters: San Diego, USA
Key Offering: Custom‑synthesized Methyl Boronic Acid for drug discovery programs

Combi‑Blocks focuses on rapid, scalable synthesis of boronic acids, offering flexible batch sizes that accommodate both early‑stage research and pilot‑scale manufacturing. Their analytical platform ensures real‑time purity monitoring, reducing batch rejection rates.

Sustainability & Growth Initiatives

• Adoption of micro‑reactor technology to cut energy usage by 18%
• Investments in renewable electricity for all U.S. facilities
• Collaboration with biotech firms to co‑develop next‑generation boron‑based therapeutics

---

8️⃣ 3. MilliporeSigma (Sigma‑Aldrich)

Headquarters: St. Louis, USA & Darmstadt, Germany
Key Offering: Broad catalog of reagent‑grade boronic acids, including Methyl Boronic Acid

Leveraging a global distribution network, MilliporeSigma supplies consistent, high‑quality reagents to pharmaceutical and academic customers worldwide. Their integrated quality management system ensures compliance with cGMP and ICH standards across all product lines.

Sustainability & Growth Initiatives

• Implementation of zero‑waste synthesis protocols in European plants
• Investment in green chemistry training programs for suppliers and customers
• Strategic acquisition of niche boron‑chemistry startups to broaden product portfolio

---

7️⃣ 4. Oakwood Chemical

Headquarters: Santa Fe Springs, USA
Key Offering: Specialty Methyl Boronic Acid for research and industrial applications

Oakwood Chemical specializes in high‑purity intermediates for fine‑chemical synthesis. Their in‑house analytical team guarantees batch purity and offers custom purity specifications tailored to client needs.

Sustainability & Growth Initiatives

• Use of biodegradable solvent systems in all production processes
• Participation in industry coalitions to set new environmental benchmarks for boron chemistry
• Expansion of contract manufacturing services for emerging biotech firms

---

6️⃣ 5. AK Scientific

Headquarters: San Diego, USA
Key Offering: Methyl Boronic Acid for research, diagnostics, and drug discovery

AK Scientific delivers high‑purity reagents to academic and industrial customers, with a focus on rapid turnaround times and flexible packaging solutions that support automated flow chemistry platforms.

Sustainability & Growth Initiatives

• Integration of renewable energy sources across all U.S. facilities
• Development of low‑toxicity waste treatment protocols
• Collaboration with pharmaceutical companies on boron‑neutron capture therapy (BNCT) research

---

5️⃣ 6. Su­zhou SuKaiLu Chemical Technology

Headquarters: Suzhou, China
Key Offering: Industrial‑grade Methyl Boronic Acid for large‑scale synthesis

Su­zhou SuKaiLu has rapidly scaled production to meet the growing demand from China’s domestic pharmaceutical sector, while maintaining strict quality controls that satisfy international standards.

Sustainability & Growth Initiatives

• Implementation of water‑recycling systems to reduce consumption by 30%
• Adoption of automated purification lines to enhance yield and reduce waste
• Partnership with Chinese universities to develop green boron precursors

---

4️⃣ 7. AllyChem

Headquarters: Shanghai, China
Key Offering: Bulk Methyl Boronic Acid for agrochemical and specialty chemical synthesis

AllyChem’s focus on cost‑effective production has positioned it as a key supplier for agrochemical manufacturers seeking affordable boronic acid intermediates.

Sustainability & Growth Initiatives

• Development of low‑energy synthesis routes using microwave assistance
• Compliance with China’s new environmental regulations on boron waste
• Expansion of contract manufacturing services for regional pharmaceutical companies

---

3️⃣ 8. Shanghai Forxine Pharmaceutical

Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade Methyl Boronic Acid for API synthesis

Shanghai Forxine’s in‑house manufacturing and quality systems enable it to supply high‑purity intermediates that meet cGMP requirements, supporting both domestic and export markets.

Sustainability & Growth Initiatives

• Investment in green chemistry training for staff
• Implementation of closed‑loop solvent recovery systems
• Collaboration with global pharma firms on BNCT‑related research

---

2️⃣ 9. Abblis Chemicals

Headquarters: Austin, USA
Key Offering: High‑purity Methyl Boronic Acid for pharmaceutical and specialty applications

Abblis Chemicals’ focus on high‑purity reagents and strict quality controls makes it a preferred partner for pharma companies developing complex small‑molecule drugs.

Sustainability & Growth Initiatives

• Use of renewable energy sources across all U.S. facilities
• Development of low‑toxicity waste treatment processes
• Expansion of production capacity to support emerging oncology APIs

---

1️⃣ 10. Anvia Chemicals

Headquarters: Houston, USA
Key Offering: Custom‑synthesized Methyl Boronic Acid for drug discovery and advanced materials

Anvia Chemicals offers flexible batch sizes and rapid delivery, supporting clients in both early‑stage research and pilot‑scale manufacturing. Their integrated quality system ensures compliance with the highest regulatory standards.

Sustainability & Growth Initiatives

• Implementation of energy‑efficient synthesis processes
• Investment in green solvent development
• Strategic partnership with biotech firms to co‑develop boron‑based therapeutics

---

Download FREE Sample Report:
Global Methyl Boronic Acid Market – View in Detailed Research Report

Get Full Report:
Global Methyl Boronic Acid Market – View in Detailed Research Report

Market Outlook

From 2025 to 2034, the Global Methyl Boronic Acid market is expected to maintain a steady upward trajectory, driven by the expanding role of the compound in pharmaceutical synthesis and the growing demand for advanced agrochemicals. The continued focus on green chemistry and process intensification is likely to reinforce the premium positioning of reagent‑grade products while opening new opportunities for industrial‑grade offerings in specialty chemical sectors.

Emerging Trends

• Integration of continuous flow chemistry platforms for Suzuki coupling reactions, improving safety and scalability
• Development of boron‑neutron capture therapy (BNCT) candidates, increasing demand for high‑purity intermediates
• Advances in bio‑based boron precursors, reducing reliance on mined boron minerals
• Expansion of agrochemical applications, particularly in precision farming and crop protection